4//SEC Filing
Davis Scott G. 4
Accession 0001209191-22-025648
CIK 0001549084other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:13 PM ET
Size
5.5 KB
Accession
0001209191-22-025648
Insider Transaction Report
Form 4
Davis Scott G.
DirectorCEO
Transactions
- Sale
Common Stock
2022-04-20$2.62/sh−4,043$10,583→ 73,815 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person on April 20, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards originally reported by the Reporting Person in a Form 4 filed with the Commission on February 22, 2022.
- [F2]The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.61 to $2.63, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.
Documents
Issuer
EKSO BIONICS HOLDINGS, INC.
CIK 0001549084
Entity typeother
Related Parties
1- filerCIK 0001908860
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 5:13 PM ET
- Size
- 5.5 KB